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In most medical specialties the success rate
and outcome ot treatment coincide and ean be
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exceeding 10% between the calculated and
measured dose, the search tor its cause was
initiated. The very tirst problem involving the
implementation ot our method to the routine,
was the number ot dosimeters required.
Transporting the dosimeter trom one unit to
another when dosimetry was requested involved
a larger error due to the instability ot the
detecting unit. Another problem was the staff
required. At tirst, physicists took care ot
dosimetry, but then technologists were trained
who are now making the majority ot
measurements. A protocol trom eaeh
measurement is included in the patient's record
and is shown tor approval to the physician.
For the evaluation ot our method a group ot
1123 patients were analysed: 850 patients with
head and neck cancer, 228 with breast caneer
and 45 with lung cancer. The number ot
measurements was at least twice as large
because each patient was irradiated trom more
than one beam.
The mean percent differences between the
calculated doses and those measured in-vivo
were -1.5 % (Standard Deviation, SD of 7.8) tor
the head and neck, +3.4% (SD=4.9) tor breast,
and -2.4% (4.3) tor the lungs.
The estimation ot the error usint atotal
differential method tor a single measurement
gives the value ot more than 10% (upper limit ot
error). However, the statistical analysis ot the
measurements on the whole group with nearly a
normai distribution provided a more realistie
error ot about 6%.
Conclusions
In-vivo dosimetry is a standard procedure in
contormal radiotherapy. It does not help to avoid
casual and even large errors since it is not done
for all beams every time. It makes it possible to
reduce the mean error in whole group of
patients, which in effect should lead to more
effective radiotherapy.
Radiotherapy is a part ot a complex treatment
administered to patients with cancer. It uses a
radiation which is generated and processed by
specialized and sophisticated equipment .
Since the beginning ot the 20th century the
main idea ot radiotherapy remained unchanged.
It is based on a proven interaction between
radiation and human tissues resulting in their
partiaI or total damage. Over the years more
knowledge has been gained, especially on
tractionation, doses and the reactions ot
different tissues and organs. The new sources
ot radiation have begun to be used, including
high energy photon end electron beam
accelerators. It became evident that major
advance in c1inical results might be achieved by
limitation ot the dose strictly to the target volume
(tumour) and by sparing normai tissues.
The issue ot critical importance was the
execution ot the prescribed treatment. When
treatment planning with the accuracy expressed
in milimmitres became possible it it had to be
proved that subsequent treatments would make
it possible to assure such accuracy. In-vivo
dosimetry was believed to be ot help in
increasing the accuracy in radiotherapy. Since
its aim was not to modity the treatment but only
to execute it according to a prescribed schedule
dosimetry should bring about only benefits when
implemented in the routine work
However, being an extensive procedure,
dosimetry consumed a lot ot effort. In regular
work, it is difficult to imagine that each beam
could be measured in-vivo tor each traction.
Measurements at more than one point tor one
beam were only considered tor special and rare
procedures such as mantle tields.
In the practice ot radiotherapy as carried out at
the Greatpoland Cancer Centre routine in-vivo
dosimetry was started in 1999, tirst applied to
the patient's head and neek, and then extended
to all patients. At least two measurements tor
each patient were made during the whole
treatment. Whenever diserepaney occurred,
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